Boulder, CO, United States of America

Martin Stanton

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 620(Granted Patents)


Location History:

  • Ocalano Beach, FL (US) (1996)
  • Stuart, FL (US) (2002)
  • Stowe, MA (US) (2004)
  • Concord, MA (US) (2009 - 2014)
  • Stow, MA (US) (2002 - 2018)
  • Boulder, CO (US) (2011 - 2023)
  • Trinity, FL (US) (2016 - 2023)

Company Filing History:


Years Active: 1996-2023

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: **Martin Stanton: Innovator in Nucleic Acid and Biomaterial Production**

Introduction

Martin Stanton, based in Boulder, CO, is a prolific inventor with an impressive portfolio of 21 patents. His work primarily focuses on methods for producing molecules that play crucial roles in biological processes, emphasizing advancements in the fields of nucleic acid and biomaterials.

Latest Patents

Stanton's most recent patents include innovative methods for producing nucleic acid molecules that bind to biological targets without inhibiting their functions. Specifically, these methods involve a systematic approach to select a candidate nucleic acid molecule that interacts with desired biological molecules, thus ensuring functionality remains intact. Additionally, he has developed degradable thiol-ene polymers that offer groundbreaking ways to link polypeptides to various moieties through radical imitated thiol-ene chemistry. These advancements facilitate the creation of biocompatible hydrogel polymers and conjugates with peptides and proteins, promising significant applications in the medical field.

Career Highlights

Throughout his career, Martin Stanton has made significant contributions to the field of biotechnology. He has worked with notable companies such as Mosaic Biosciences, Inc. and Dexela Limited, where he has applied his expertise to develop cutting-edge solutions that address complex biological challenges. His innovative spirit and technical knowledge have led to numerous advancements that are shaping the future of biomedical research.

Collaborations

Stanton's work has often been collaborative, drawing insights and support from talented colleagues like Alexander Stewart and Peter D Mariner. These partnerships have enriched his research endeavors, enabling him to push the boundaries of innovation further and realize the potential of his groundbreaking inventions.

Conclusion

Martin Stanton's contributions to patent technology are profound, particularly in the areas of nucleic acid and biomaterial production. His extensive experience and innovative mindset continue to inspire advancements in biotechnology, making a significant impact on both research and practical applications in the medical field. The future holds exciting prospects for Stanton and his continued work in the realm of scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…